A61K 33/22
Boron compounds
A61K33/22 (Boron compounds) appears on 274 US grants and 412 published applications in this corpus.
Search patents in A61K- Granted patents
- 274
- Published applications
- 412
- Assignees
- 218
- Inventors
- 682
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 5 | 0 |
| 1999 | 4 | 0 |
| 2000 | 6 | 0 |
| 2001 | 4 | 2 |
| 2002 | 12 | 12 |
| 2003 | 8 | 10 |
| 2004 | 5 | 13 |
| 2005 | 6 | 10 |
| 2006 | 7 | 16 |
| 2007 | 3 | 13 |
| 2008 | 3 | 16 |
| 2009 | 4 | 16 |
| 2010 | 6 | 13 |
| 2011 | 5 | 17 |
| 2012 | 4 | 12 |
| 2013 | 12 | 19 |
| 2014 | 14 | 22 |
| 2015 | 19 | 22 |
| 2016 | 15 | 22 |
| 2017 | 20 | 19 |
| 2018 | 15 | 19 |
| 2019 | 7 | 18 |
| 2020 | 10 | 12 |
| 2021 | 12 | 19 |
| 2022 | 11 | 23 |
| 2023 | 8 | 12 |
| 2024 | 17 | 26 |
| 2025 | 6 | 17 |
| 2026 | 6 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pharmaceutical compositions for relief of COVID-19 symptoms and methods of producing and using them15 Sep 2026US 12,734,183 B2
- Electrochemically activated salt solution23 Jun 2026US 12,661,373 B2Azad Pharma AG
- TREM2 agonists for the stimulation of microglia and methods of identification16 Jun 2026US 12,653,803 B2The Translational Genomics Research Institute
- Intestinal tissue enhanced with therapeutic salts16 Jun 2026US 12,653,927 B2Avalon Medical, Ltd.
- Dietary macro/micronutritional compositions and applications thereof19 May 2026US 12,629,373 B2
- Intestinal tissue enhanced with therapeutic salts1 Oct 2026US 2026/0295122 A1Avalon Medical, Ltd.
- Bioglass composition3 Sep 2026US 2026/0256832 A1Imam Abdulrahman Bin Faisal University
- Use of boron for the treatment of leishmaniasis disease3 Sep 2026US 2026/0256833 A1Yeditepe Universitesi
- Formulations for the treatment of skin diseases and conditions13 Aug 2026US 2026/0232571 A1Keylika, Inc.
- Use of boron for the treatment of leishmaniasis disease of neuronal origin13 Aug 2026US 2026/0232726 A1Yeditepe Universitesi
Most cited
By later US patents
- Drug delivery device463US 6,595,956 B12003
- Antimicrobial composition composed of controlled release glasses141US 6,143,318 AGiltech Limited · 2000
- Drug delivery device85US 7,384,413 B2Elan Pharma International Limited · 2008
- Composition for promoting healthy bone structure76US 6,447,809 B1Metagenics, Inc. · 2002
- Ophthalmic compositions containing galactomannan polymers and borate69US 6,403,609 B1Alcon Manufacturing, Ltd. · 2002